fezakinumab

Ligand id: 9281

Name: fezakinumab

Immunopharmacology Disease
Disease X-Refs Comment References
Atopic dermatitis Disease Ontology: DOID:3310
OMIM: 603165
Active Phase 2 study NCT01941537.
Psoriasis Disease Ontology: DOID:8893
Completed Phase 1 trial for psoriasis (see NCT00563524).
Rheumatoid arthritis Disease Ontology: DOID:7148
OMIM: 180300
Completed Phase 2 trial for RA (see NCT00883896).